| Bacteriophages and microbial interactions | Lifetime | 67 | FR 6 | 99.61 |
| Legionella and Acanthamoeba research | Lifetime | 7 | FR 3 | 99.43 |
| COVID-19 Clinical Research Studies | Lifetime | 121 | FR 5 | 99.29 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 137 | FR 6 | 99.36 |
| SARS-CoV-2 detection and testing | Lifetime | 34 | FR 1 | 99.03 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 84 | FR 6 | 99.44 |
| Bartonella species infections research | Lifetime | 8 | FR 5 | 99.17 |
| Vector-borne infectious diseases | Lifetime | 97 | FR 10 | 98.97 |
| Microbial infections and disease research | Lifetime | 135 | FR 6 | 98.57 |
| Plant Virus Research Studies | Lifetime | 196 | FR 13 | 98.62 |
| Streptococcal Infections and Treatments | Lifetime | 217 | FR 12 | 98.56 |
| Viral Infections and Vectors | Lifetime | 405 | FR 26 | 98.69 |
| Vibrio bacteria research studies | Lifetime | 210 | FR 13 | 98.31 |
| Genomics and Phylogenetic Studies | Lifetime | 735 | FR 33 | 98.30 |
| Bacillus and Francisella bacterial research | Lifetime | 151 | FR 14 | 97.17 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 657 | FR 47 | 97.59 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 283 | FR 21 | 95.96 |
| Bacterial biofilms and quorum sensing | Lifetime | 524 | FR 24 | 97.18 |
| Rabies epidemiology and control | Lifetime | 269 | FR 25 | 96.47 |
| Parasitic Infections and Diagnostics | Lifetime | 443 | FR 26 | 96.63 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 151 | FR 12 | 93.16 |
| Whipple's Disease and Interleukins | Lifetime | 64 | FR 9 | 93.08 |
| Leptospirosis research and findings | Lifetime | 333 | FR 17 | 90.78 |
| Dermatological diseases and infestations | Lifetime | 398 | FR 28 | 90.75 |
| Plant and Fungal Interactions Research | Lifetime | 761 | FR 39 | 91.46 |
| Infections and bacterial resistance | Lifetime | 464 | FR 32 | 85.13 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 238 | FR 9 | 98.94 |
| COVID-19 Clinical Research Studies | 2021-2025 | 380 | FR 19 | 98.18 |
| SARS-CoV-2 detection and testing | 2021-2025 | 97 | FR 5 | 97.24 |
| Bacteriophages and microbial interactions | 2021-2025 | 136 | FR 6 | 96.00 |
| Animal Virus Infections Studies | 2021-2025 | 531 | FR 8 | 89.51 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 980 | FR 17 | 88.13 |
| Bacillus and Francisella bacterial research | 2021-2025 | 204 | FR 9 | 84.84 |
| Microbial infections and disease research | 2021-2025 | 362 | FR 12 | 85.48 |
| Plant Virus Research Studies | 2021-2025 | 933 | FR 25 | 83.96 |
| Herpesvirus Infections and Treatments | 2021-2025 | 930 | FR 43 | 77.63 |
| Poxvirus research and outbreaks | 2021-2025 | 766 | FR 23 | 68.64 |
| Legionella and Acanthamoeba research | 2021-2025 | 374 | FR 15 | 57.56 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 621 | FR 36 | 52.78 |
